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Exercise and Lipoprotein Levels
To the Editor:
I recently reviewed the data and conclusions in the article by Brownell et al. The authors indicate that their data show moderate exercise to have "different effects on men and women" with respect to lipoprotein levels. Their results fail to support this conclusion; rather, they suggest that men and women have similar lipoprotein responses to exercise.
The authors' data show that the male and female groups did not begin the investigation with comparable lipoprotein levels. Women had substantially lower mean levels of cholesterol (186.8 vs 207 mg/dl), lowdensity lipoprotein (LDL) cholesterol (111.8 vs 132.8 mg/dl), and triglycerides (71.5 vs 176.4 mg/dl). The women also demonstrated substantially higher values of mean high-density lipoprotein (HDL) cholesterol (58.6 vs 42.2 mg/dl) and HDL/LDL cholesterol ratio (0.572 to 0.351). The authors' data (tables 1 and 2) report similar changes in levels of cholesterol (both significantly decreased), HDL cholesterol (no significant change), and LDL cholesterol (no significant change) in both men and women after 10 weeks of training.
When the male and female data are combined, rather than obscuring these important differences (table 3) as the authors suggest, the combination affirms the similarity of their responsiveness. Separately, neither male nor female groups reported significant decreases in LDL cholesterol levels. Only when male and female data were combined was a statistical decrease in LDL cholesterol level reached. If the lipoprotein response to exercise was dissimilar in males with regard to females, we would not expect a combination of these two groups to result in a significant change, as neither group generated statistical significance when analyzed separately.
The authors do report differences in the percent of lipoproteins in men compared with women. However, the concluding remarks that plasma lipoprotein "levels" improve much more in men than women is not supported. "Percent change" may be dissimilar between the male and female groups, but that is more likely a function of initial lipid values rather than a real difference. For example, the women would have to increase their HDL cholesterol level 1.38 mg/dl for every l-mg/dl increase demonstrated by the men in this study to show an equivalent percent change. This would be necessary even though women began this exercise study with an HDL cholesterol level more than 38.8% higher than men. Clearly, the percent change in these two dissimilar groups cannot accurately measure the lipoprotein response to exercise.
In summary, the level of response among both male and female groups were similar. Combining the data appears to enhance this parity of response rather than obscure their dissimilarity. Both men and women displayed comparable changes in lipoprotein levels after 10 weeks of exercise training. LINN The authors reply: To the Editor: We received with interest Dr. Goldberg's interpretation of the data we presented.
First, there was indeed a tendency for LDL cholesterol to decrease in both men and women. In the men however, the decrease was somewhat larger. It almost reached significance in terms of mass concentration (p 0.057) and was significant in terms of percent change, although 1346 fewer men than women were studied. We feel that the observations indicated a greater LDL cholesterol response in men. Since the changes were in the same direction, combining the data from men and women made the overall change statistically significant, but of course failed to discriminate the difference between the groups. The changes in HDL cholesterol were in opposite directions in the two groups. HDL cholesterol in men tended to increase and those in women tended to decrease, although in neither group was the change in mass concentration statistically significant. Since the changes were in opposite directions, combination of the data from both groups did not alter statistical significance, but did obscure the tendency toward opposite changes in the two groups.
The change in plasma triglyceride levels was also different in the two groups. Triglycerides were significantly lower in men and tended to increase slightly in the women. These changes were in the directions expected based on the HDL cholesterol changes in the two groups. Again, we feel that, taken together, the observations indicated differential responses to the exercise program in men and women.
Finally, we feel that the examination of percent changes in lipoprotein concentration can be useful. First, women maintain considerably higher plasma levels of HDL cholesterol than men. A change of 1 mg/dl in the level of HDL cholesterol would be expected to represent a smaller perturbation of the physiologic steady state (e.g., change in synthetic or clearance rates) in women than in men. In this case, normalizing for steady-state concentration may give a better appreciation for the extent to which the individual's ability to maintain a particular HDL cholesterol level has changed.
Second, in terms of cardiovascular risk, such a change may be much more significant in the men, since the mean HDL cholesterol level in the men was in the range where risk changes dramatically with small changes in HDL cholesterol concentration.
For these reasons, we feel that the consideration of both mass changes and percent changes gives more information than the use of either measure alone.
KELLY Goldman et al. 1 are to be complimented on their informative inquiry into the decline in coronary heart disease (CHD) mortality rates in the 1970s. However, more comprehensive studies may be necessary to fill some of the following gaps in our knowledge left by their report. The authors presented only national myocardial infarction and ischemic heart disease mortality rate trends for comparison with Boston area myocardial infarction hospital admission and mortality rate trends.
(1) How did age-and sex-specific CHD mortality rates in the same surveillance area and referent population at risk change during the period of the report?
(2) The population estimation procedures used for computing hospitalization rates involved several assumptions that could seriously compromise the accuracy of the rates. Of particular concern is obtaining the 1978 population by extrapolation without using the now available 1980 census data, which have surprised many demographers in their degree of deviation from such estimates. Determining the at-risk population from the percentage of discharges from a given town is also worrisome.
Would the magnitude of such errors be sufficient to drastically alter the conclusions of the report? (3) Should the overall case-fatality rates be age-adjusted to some standard patient population, in view of the upward trend in age of CHD patients seen elsewhere?t (4) How valid are the assumptions regarding coronary care unit utilization? How sensitive are the conclusions to errors in these assumptions?
(5) Is a conclusion about a substantial fall in the percentage of CHD deaths occurring outside the hospital warranted based on comparisons between national mortality rates and hospital mortality rates in a subset of Boston hospitals?
(6) Why were discharge rates not calculated for hospital groups A and B combined? Would this not improve accuracy of estimation of population at risk and reduce the effects of shifts in utilization patterns? How similar were groups A and B to each other and to U.S. hospitals?
(7) The statistical significance of a trend in mortality rates would best be assessed by fitting a linear or polynomial regression to data from 10 years or so. The curves for various areas and causes could be compared statistically by repeated measures analysis of variance. When relatively small areas such as counties or cities are so examined, year-to-year variations in rates are quite large. Conclusions drawn from examining, say, 10 years' data might be quite different from those drawn from comparing the first and last years of the period using a simple chi-square test, since the latter cannot take into account the year-to-year variation. How confident can one be that the lines connecting the various pairs of Boston data points would accurately represent the corresponding trends if data from 1968 to 1978 were available? Would the apparent differences in slopes (e.g., old vs young admission rates) be significantly different?
The Minnesota Heart Survey is collecting data on CHD mortality, hospitalization, case-fatality, acute myocardial infarction care and risk factor trends in a seven-county metropolitan area between 1970 and 1985.2. 3 Preliminary results indicate a striking fall in out-of-hospital CHD death rates, with a smaller decline in in-hospital mortality.5 The roles of changing myocardial infarction incidence, recurrence, case fatality and survivorship, as well as hospital and prehospital coronary care, are being assessed in this well defined population. The results of this study will extend the information provided by the valuable contribution of Goldman et al.
R. F. GILLUM, M.D. Laboratory of Physiological Hygiene
School of Public Health University of Minnesota Minneapolis, Minnesota
The authors reply: To the Editor:
We are pleased that Dr. Gillum found our report to be informative and valuable. Several of the issues raised in his letter were addressed in our article, but they may deserve further emphasis.
(1) As noted in our article, declines in the calculated Massachusetts and estimated eastern Massachusetts age-adjusted ischemic heart disease mortality rates were parallel to the national declines. For patients age 40 years and older, eastern Massachusetts and overall Massachusetts ischemic heart disease mortality rates declined from 950 per 100,000 in 1970 to 800 per 100,000 in 1977, indicating that although the mortality rates were slightly higher in Massachusetts, they declined by the same amount as did overall U.S. mortality rates. Similarly, acute myocardial infarction mortality rates declined from 490 per 100,000 to 380 per 100,000 in Massachusetts between 1970 and 1977, a change that was virtually identical to the change in the United States acute myocardial infarction mortality rates.
(2) At the time of our investigation, 1980 census data were not available. In fact, age-specific data are still not available to us at the time that this response is being written. Thus, our determination of the at-risk population represented the best available data.
(3) Because the trends were in different directions among different ages, our reported age-specific data are preferable to age-adjusted data.
(4) We clearly state that we can only estimate coronary care unit bed utilization because we do not have length-of-stay figures from all hospitals. Our assumptions yielded an estimate that 35% of CCU bed days were occupied with acute myocardial infarction patients, an estimate that was remarkably similar to the 37% rate reported in another study in which precise lengths of stay were available for analysis. ' (5) As noted above, the trends in our geographic area were so similar to nationwide trends that the percentages reported in our paper should be valid.
(6) Age-specific data were not available for the group B hospitals. Based on the similarities of group A and group B hospitals in terms of the size of the hospital, the size of the coronary care unit, the average number of infarction patients between 1973 and 1978, we felt that it was likely that events occurring in group B hospitals were similar to those in group A hospitals. Because the group B hospitals did not have computerized data, case-specific information could be obtained only by chart review of patients from the two years. Resources were not available for such a case-by-case review.
(7) More data would always be preferable. If it had been practical to obtain data on a yearly basis, linear regression or a chi-square analysis for linear trend would have been performed. However, before 1973, the number of hospitals with computerized data was too small to warrant analysis. Analysis of data for each year between 1973 and 1978 would have been possible, but substantially more laborious and expensive. Because of the consistent downward trend in national and local mortality rates, we did not feel that yearly local hospital data would be so important.
We eagerly await the results of the Minnesota Heart Survey, a project whose comprehensive scope and expense is far greater than our epidemiologic investigation. We are also gratified that the early results of the Minnesota Heart Survey appear to substantiate our findings.
